1. Home
  2. GBIO vs DSP Comparison

GBIO vs DSP Comparison

Compare GBIO & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.31

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$11.83

Market Cap

184.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBIO
DSP
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
35.4M
184.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GBIO
DSP
Price
$5.31
$11.83
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$10.67
$18.50
AVG Volume (30 Days)
40.1K
234.0K
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.49
EPS
N/A
0.10
Revenue
$15,270,000.00
$324,131,000.00
Revenue This Year
N/A
$17.79
Revenue Next Year
N/A
$17.72
P/E Ratio
N/A
$118.61
Revenue Growth
N/A
22.97
52 Week Low
$3.00
$8.11
52 Week High
$13.00
$26.33

Technical Indicators

Market Signals
Indicator
GBIO
DSP
Relative Strength Index (RSI) 47.14 64.86
Support Level $5.22 $11.10
Resistance Level $5.64 $12.48
Average True Range (ATR) 0.25 0.52
MACD 0.04 0.02
Stochastic Oscillator 42.37 72.59

Price Performance

Historical Comparison
GBIO
DSP

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: